A phase II study of menogaril in low-grade non-Hodgkin's lymphoma

Jamey Skillings(Ottawa Regional Cancer Foundation), David Walde(Ontario Institute for Cancer Research), Savita Verma(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Joseph L. Pater(Queen's University), C. Cripps(Canadian Partnership Against Cancer), E. Eisenhauer
Investigational New Drugs
February 1, 1991
10.1007/bf00194551
Cited by 6

Related Papers

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
|New England Journal of Medicine|2003|1.8k
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291